Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMTAlicia Rovó, Luuk Gras, Brian Piepenbroek, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell TherapyConrad-Amadeus Voltin, Sarah Flossdorf, Lars Kurch, et al.Nature Communications|August 4, 2019
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancerMarcel A Dammert, Johannes Brägelmann, Rachelle R Olsen, et al.Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.Journal of Cancer Research and Clinical Oncology|September 28, 2022
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registryMaher Hanoun, Leo Ruhnke, Michael Kramer, et al.Cell Reports|September 21, 2017
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline CarcinomaJohannes Brägelmann, Marcel A Dammert, Felix Dietlein, et al.Nature Communications|December 18, 2025
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progressionAriadne Androulidaki, Fanyu Liu, Christina M Bebber, et al.Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.Nature Communications|November 9, 2018
Overcoming EGFR<sup>G724S</sup>-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitorsJana Fassunke, Fabienne Müller, Marina Keul, et al.Pageof 9